Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study - Curtis, J R; Sarsour, K; Napalkov, P (Arthritis Res Ther, 2015)